Massachusetts General Hospital Upgraded to the Latest Version of QC PathFinder®
CAMBRIDGE, MA, – Massachusetts General Hospital (MGH) is the most recent hospital to be upgraded to QC PathFinder® Version 5.1 and joins an increasing number of hospitals using the latest version. MGH is one of the earliest adopters of Vecna’s electronic infection surveillance software and has been an important contributor to the development of QC PathFinder®. “MGH has been a valuable development partner since the beginning and we are delighted to get them upgraded to Version 5.1,” says Ron Urwongse, Product Manager of QC PathFinder®. Version 5.1 supports submission of HAI reports to the CDC’s National Health Safety Network (NHSN) program, and also includes support for non-culture tests such as Hepatitis, Influenza, and Varicella. Finally, support for pharmacy reports is available with this latest version, allowing customers to quickly adopt reports for adverse-drug events, IV-PO interchange, and restricted drugs.
About QC PathFinder®
QC PathFinder® is a web-based, automated infection control solution that helps hospitals improve quality of care by preventing hospital-acquired infections (HAIs) through real-time data monitoring. QC PathFinder® is capable of automated NHSN submission which greatly reduces the amount of time infection preventionists spend on the submission process. Learn more at Quality Patient Safety
About Vecna Medical
Vecna Medical is a driving force in innovative healthcare IT, leading the industry in patient self-service solutions and electronic infection surveillance solutions. Our clients include the Department of Veterans Affairs, US Department of Defense, Massachusetts General Hospital, and Johns Hopkins Hospital. Vecna Medical is a division of Vecna Technologies, Inc. Learn more at Vecna Medical